Dna And Stuff (JC July 31, 2008)
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

Dna And Stuff (JC July 31, 2008)

on

  • 735 views

This was a journal club presentation I made. I don't remember what it was specifically about.

This was a journal club presentation I made. I don't remember what it was specifically about.

Statistics

Views

Total Views
735
Views on SlideShare
735
Embed Views
0

Actions

Likes
0
Downloads
3
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Dna And Stuff (JC July 31, 2008) Presentation Transcript

  • 1. DNA and Stuff… By:
  • 2. Meanings of words in the Title in the context of said title The - definite article Mammalian - pertaining to the class Mammalia; characteristic of mammals DNA - deoxyribonucleic acid: an extremely long macromolecule that is the main component of chromosomes and is the material that transfers genetic characteristics in all life forms Replication - the process by which double-stranded DNA makes copies of itself Elongation – the process during transcription by which RNA is made from a compliment DNA strand Checkpoint - a place along a road, border, etc., where travelers are stopped for inspection Implication - something implied or suggested as naturally to be inferred or understood of Chk1 - CHK1 is one of two serine/threonine kinases involved in the induction of cell cycle checkpoints in response to DNA damage and replicative stress. and - conjunction Relationship - a connection, association, or involvement. with - accompanied by; accompanying Origin Firing - commencement at the beginning of As - in the manner Determined by Single DNA Molecule and Single Cell Analyses – what we do
  • 3. But Ant… I don’t understand all that fancy talk you just said.
  • 4. Let’s Start with Elongation According to some, this is the step of transcription (the whole process of initiation, elongation, and termination of RNA synthesis) where a template strand of DNA is used to encode RNA in RNA synthesis. An RNA Polymerase (the globule that reads the DNA strand and adds nucleotides to the RNA strand) reads a template from the 3’-> 5’ end but is said to transcribe 5’-> 3’ because it is a duplicate of the coding strand (the non- template strand). This means biologists make things Regulation of Elongation (fork velocity) annoying for us even though they think it makes it simpler. Why is it called this? Because those pictures above look like forks.
  • 5. Now on to CHK1 CHK1 and CHK2 are two serine/threonine kinases involved in the induction of cell cycle checkpoints in response to DNA damage and replicative stress. CHK1 is essential for the G2/M DNA damage-induced checkpoint, and inhibitors of this kinase are expected to lead to sensitisation of tumours to both radiotherapy in the form of ionising radiation (IR) and chemotherapeutic agents which are used in the clinic for the treatment of cancer. Recent studies suggest that unlike CHK1, CHK2 is not essential for the initiation of the G2 checkpoint, and there is evidence of a functional link between the tumour suppressor p53 and CHK2. In this context, CHK2 inhibition would be predicted to reduce p53-induced apoptosis and protect normal tissues from chemotherapy. The recent discovery that activated CHK2 phosphorylates the pro-apoptotic transcription factor E2F resulting in protein stabilisation, activation and E2F-dependent apoptosis may still provide a therapeutic strategy for increasing tumour cell susceptibility to DNA damage. Inhibition of CHK2 in cancer cells with defective checkpoints, may allow tumour cells to remain proliferating and thus become more sensitive to IR or chemotherapy. Assays have therefore been developed in order to screen for inhibitors of both CHK1 and CHK2 and a number of hits have been identified that are now undergoing evaluation for further drug development. A collaboration has also been initiated with Professor L Pearl (Section of Structural Biology) to crystallise the CHK2 kinase, to aid drug development on this project. That’s a mouth full!.?,;:*
  • 6. Simply Stated… A kinase - a type of enzyme that transfers phosphate groups from high-energy donor molecules, such as ATP, to specific target molecules CHK1 G2/M checkpoints include the checks for damaged DNA, unreplicated DNA, and checks that ensure that the genome is replicated once and only once per cell cycle. If cells pass these checkpoints, they follow normal Used in G2/M What is transition to the M phase. However, if checkpoint. this? any of these checkpoints fail, mitotic entry is prevented by specific G2/M checkpoint events
  • 7. Not my work CELL CYCLE CHECKPOINTS CYCLIN E / cdk2 CYCLIN A/ cdk2 S G1 G2 CYCLIN D / cdk4,5,6 M CYCLIN B/ cdc2
  • 8. Not my work CELL CYCLE CHECKPOINTS • MITOSIS ENTRY (G2/M) – Replication Complete – Growth/ Protein Synthesis adequate – No DNA Damage • S-PHASE ENTRY (G1/S) – Mitosis Complete ?signal - cyclin degradation – Growth/ Protein Synthesis (G1 CYCLINS) – No DNA Damage • OTHERS – MITOSIS EXIT: ?coupling to S-phase – S PHASE : coupling to mitosis • also in response to DNA damage – G1 sequence of events • signaling from cell surface
  • 9. Not my work DNA Damage - Cell Cycle Arrest damage dependent checkpoints G1 - S - G2 G1 - S - G2 CELL wild-type No. DNA content DNA content X-ray treated asynchronous G1/S block loss of G1/S in p53 deficient G2/M block cells (6-9 hours)
  • 10. Not my work G2/M CHECKPOINT IN RESPONSE TO DAMAGE • MAMMALIAN CELLS – chk1/chk2 kinases involved – ?upstream pathway uncertain ?ATM ?ATR – many other proteins: e.g. 9-1-1 complex • YEAST – RAD9: radiation sensitive (resistant with MBC = G2 hold) • cf RAD52 = radiation sensitive +/- MBC – RAD17,24; MEC3 = late S signal (RAD9) – MEC1,2 = mitosis entry (late S or pre-S)
  • 11. Not my work S PHASE CHECKPOINT IN RESPONSE TO DAMAGE • MAMMALIAN CELLS – involves Rad50/mre11/NBS1 – ?upstream pathway uncertain ?ATM ?ATR – many other proteins: ?BRCA1?; 9-1-1 complex • YEAST (pombe) – RAD9/ RAD1/ Hus1: – cdc18 – Rad17, Rad24
  • 12. Is your hair a mess? Is it hard to comb? Well do we have the solution for you… What a mess!! It’s new!!
  • 13. Welcome Back • Time for some pictures…
  • 14. Figure 2 Figure 2. The inter-origin distance is linearly correlated with the velocity of neighboring forks. (A and B) Schemes representing two DNA fibers with three and two origins of replication. The forks travel faster when only two origins are activated, depicted by longer green and red signals, because a longer segment of DNA must be duplicated in the same amount of time. (C) Linear correlation between inter-origin distance and fork velocity for neighboring origins. The dot plot, which supports the scheme shown above, is obtained by the analysis of primary keratinocytes, where a linear correlation of 0.65 was calculated.19 (D and E) Model depicting two replication foci where each DNA fiber is folded into a replication factory. The left factory (D) contains smaller loops, with denser origins and slower forks than the right factory (E).10
  • 15. Figure 3
  • 16. Figure 4 Figure 4. Single-cell analyses of the DNA replication checkpoints. (A) Confocal microscopy images of representative cells immediately after CPT treatment (HT29 cells were incubated with IdU for 15 minutes, then 1 mM CPT was added for an additional 30 minutes). The top panels depict IdU-labeled replication foci patterns in early, mid, and late S phase. The bottom panels depict g-H2AX foci colocalizing with replication foci. (B) Sequential pulse-labeling of replication foci for untreated, CPT-treated, and CPT+CHIR124-treated cells. Representative cells at different times are shown. In untreated conditions, when a time lapse is introduced between the two pulses, the red and green foci are separate entities, indicating that new origins (in red) were activated at new sites during the second pulse, while the foci labeled during the first pulse have completed replication (no IdU incorporation into these pre-existing sites). After CPT treatment, the second pulse is not incorporated, indicating that new origins are inhibited. Administration of the Chk1 inhibitor CHIR124 (0.1 mM) restored the incorporation of IdU and origin firing.10